172 related articles for article (PubMed ID: 16737869)
1. Efficacy of oral erythromycin for treatment of feeding intolerance in preterm infants.
Nuntnarumit P; Kiatchoosakun P; Tantiprapa W; Boonkasidecha S
J Pediatr; 2006 May; 148(5):600-5. PubMed ID: 16737869
[TBL] [Abstract][Full Text] [Related]
2. Oral erythromycin for treatment of feeding intolerance in preterm infants: a preliminary report.
Sekteera W; Nuntnarumit P; Supapannachart S
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1177-82. PubMed ID: 12549792
[TBL] [Abstract][Full Text] [Related]
3. Erythromycin and feeding intolerance in premature infants: a randomized trial.
Aly H; Abdel-Hady H; Khashaba M; El-Badry N
J Perinatol; 2007 Jan; 27(1):39-43. PubMed ID: 17036029
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled trial of a high dose of oral erythromycin for the treatment of feeding intolerance in preterm infants.
Mansi Y; Abdelaziz N; Ezzeldin Z; Ibrahim R
Neonatology; 2011; 100(3):290-4. PubMed ID: 21701222
[TBL] [Abstract][Full Text] [Related]
5. Use of oral erythromycin for the treatment of gastrointestinal dysmotility in preterm infants.
Ng PC
Neonatology; 2009; 95(2):97-104. PubMed ID: 19218823
[TBL] [Abstract][Full Text] [Related]
6. Erythromycin for feeding intolerance in preterm infants.
Ng E; Shah V
Cochrane Database Syst Rev; 2000; (2):CD001815. PubMed ID: 10796273
[TBL] [Abstract][Full Text] [Related]
7. Erythromycin for treatment of feeding intolerance in preterm infants.
Su BH; Lin HC
J Pediatr; 2007 Feb; 150(2):e30; author reply e31. PubMed ID: 17236878
[No Abstract] [Full Text] [Related]
8. Erythromycin for feeding intolerance in preterm infants.
Ng E; Shah V
Cochrane Database Syst Rev; 2001; (2):CD001815. PubMed ID: 11406010
[TBL] [Abstract][Full Text] [Related]
9. A placebo-controlled trial of low-dose erythromycin to promote feed tolerance in preterm infants.
Oei J; Lui K
Acta Paediatr; 2001 Aug; 90(8):904-8. PubMed ID: 11529540
[TBL] [Abstract][Full Text] [Related]
10. Can prophylactic oral erythromycin reduce time to full enteral feeds in preterm neonates?
Patole SK; Almonte R; Kadalraja R; Tuladhar R; Muller R; Whitehall JS
Int J Clin Pract; 2000 Oct; 54(8):504-8. PubMed ID: 11198727
[TBL] [Abstract][Full Text] [Related]
11. Erythromycin for treatment of feeding intolerance in preterm infants.
Mascarenhas S; Lal M
J Pediatr; 2007 Feb; 150(2):e30-1; author reply e31. PubMed ID: 17236879
[No Abstract] [Full Text] [Related]
12. Erythromycin for the prevention and treatment of feeding intolerance in preterm infants.
Ng E; Shah VS
Cochrane Database Syst Rev; 2008 Jul; (3):CD001815. PubMed ID: 18646077
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of intermediate-dose oral erythromycin on very low birth weight infants with feeding intolerance.
Ng YY; Su PH; Chen JY; Quek YW; Hu JM; Lee IC; Lee HS; Chang HP
Pediatr Neonatol; 2012 Feb; 53(1):34-40. PubMed ID: 22348492
[TBL] [Abstract][Full Text] [Related]
14. A controlled trial of erythromycin and UDCA in premature infants during parenteral nutrition in minimizing feeding intolerance and liver function abnormalities.
Gokmen T; Oguz SS; Bozdag S; Erdeve O; Uras N; Dilmen U
J Perinatol; 2012 Feb; 32(2):123-8. PubMed ID: 21566568
[TBL] [Abstract][Full Text] [Related]
15. Intravenous low-dose erythromycin administration for infants with feeding intolerance.
Nogami K; Nishikubo T; Minowa H; Uchida Y; Kamitsuji H; Takahashi Y
Pediatr Int; 2001 Dec; 43(6):605-10. PubMed ID: 11737737
[TBL] [Abstract][Full Text] [Related]
16. Benefits of a standardised feeding regimen during a clinical trial in preterm neonates.
Patole SK; Kadalraja R; Tuladhar R; Almonte R; Muller R; Whitehall JS
Int J Clin Pract; 2000 Sep; 54(7):429-31. PubMed ID: 11070566
[TBL] [Abstract][Full Text] [Related]
17. Erythromycin fails to improve feeding outcome in feeding-intolerant preterm infants.
ElHennawy AA; Sparks JW; Armentrout D; Huseby V; Berseth CL
J Pediatr Gastroenterol Nutr; 2003 Sep; 37(3):281-6. PubMed ID: 12960650
[TBL] [Abstract][Full Text] [Related]
18. Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants.
Ng PC; So KW; Fung KS; Lee CH; Fok TF; Wong E; Wong W; Cheung KL; Cheng AF
Arch Dis Child Fetal Neonatal Ed; 2001 May; 84(3):F177-82. PubMed ID: 11320044
[TBL] [Abstract][Full Text] [Related]
19. Morphine analgesia and gastrointestinal morbidity in preterm infants: secondary results from the NEOPAIN trial.
Menon G; Boyle EM; Bergqvist LL; McIntosh N; Barton BA; Anand KJ
Arch Dis Child Fetal Neonatal Ed; 2008 Sep; 93(5):F362-7. PubMed ID: 18089630
[TBL] [Abstract][Full Text] [Related]
20. High-dose oral erythromycin decreased the incidence of parenteral nutrition-associated cholestasis in preterm infants.
Ng PC; Lee CH; Wong SP; Lam HS; Liu FY; So KW; Lee CY; Fok TF
Gastroenterology; 2007 May; 132(5):1726-39. PubMed ID: 17484870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
